Phase II study of liposomal vincristine (lipoV) in relapsed or refractory adult acute lymphoblastic leukemia (ALL).

被引：0
|
作者：
Thomas, DA
Sarris, A
O'Brien, S
Cortes, J
Giles, FJ
Faderl, S
Keating, MJ
Burge, C
Cabanillas, F
Kantarjian, H
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[3] Inex Pharmaceut Corp, Burnaby, BC, Canada
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4269
引用
收藏
页码：238B / 238B
页数：1
相关论文
共 50 条
  • [1] Trial initiated for liposomal vincristine in relapsed/refractory acute lymphoblastic leukemia
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (10): : 1292 - 1292
  • [2] Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    Wetzler, Meir
    Thomas, Debora A.
    Wang, Eunice S.
    Shepard, Robert
    Ford, Laurie A.
    Heffner, Thompson L.
    Parekh, Samir
    Andreeff, Michael
    O'Brien, Susan
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 430 - 434
  • [3] Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature
    Pathak, Priyanka
    Hess, Rosemary
    Weiss, Mark A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2014, 5 (01) : 18 - 24
  • [4] A phase II trial of arsenic trioxide (AT) for relapsed and refractory acute lymphoblastic leukemia (ALL).
    Litzow, MR
    Lee, S
    Bennett, JM
    Gallagher, RE
    Paietta, EM
    Rousey, SR
    Tallman, MS
    BLOOD, 2003, 102 (11) : 260B - 260B
  • [5] A phase II feasibility study of cytarabine and idarubicin combination in relapsed or refractory adult acute lymphoblastic leukemia
    Hafeez, M.
    Shaharyar, A.
    Zia, N.
    Rasheed, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Phase II study of marqibo in adult patients with refractory or relapsed philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL)
    O'Brien, S. M.
    Aulitzky, W.
    Ben Yehuda, D.
    Lister, J.
    Schiller, G. J.
    Selter, K.
    Smith, S. E.
    Stock, W.
    Silverman, J. A.
    Kantarjian, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Phase I/II study of clofarabine plus cyclophosphamide in adults with relapsed and refractory acute lymphoblastic leukemia (ALL)
    Faderl, Stefan
    Thomas, Deborah A.
    Gandhi, Varsha
    Borthakur, Gautam
    Huang, Xuelin
    Plunkett, William
    Burger, Jan
    Cortes, Jorge
    O'Brien, Susan
    Ravandi, Farhad
    Bretz, Jennie
    Kwari, Monica
    Kantarjian, Hagop M.
    BLOOD, 2007, 110 (11) : 152B - 152B
  • [8] Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia
    Kadia, Tapan M.
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    O'Brien, Susan
    Estrov, Zeev
    Ravandi, Farhad
    Jabbour, Elias
    Pemmaraju, Naveen
    Daver, Naval
    Wang, Xuemei
    Jain, Preetesh
    Pierce, Sherry
    Brandt, Mark
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Borthakur, Gautam
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (02) : 120 - 124
  • [9] Phase II Study of Hyper-Cmad with Liposomal Vincristine (Marqibo) for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
    Sasaki, Koji
    Jabbour, Elias J.
    Khouri, Maria
    Thomas, Deborah A.
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Short, Nicholas J.
    Issa, Ghayas C.
    Kadia, Tapan
    Jones, Emily
    Garris, Rebecca
    Cortes, Jorge E.
    O'Brien, Susan M.
    Kantarjian, Hagop M.
    BLOOD, 2017, 130
  • [10] Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
    Jeha, S
    Gaynon, PS
    Razzouk, BI
    Franklin, J
    Kadota, R
    Shen, V
    Litchtman-Jones, L
    Rytting, M
    Bomgaars, LR
    Rheingold, S
    Ritchey, K
    Albano, E
    Arceci, RJ
    Goldman, S
    Griffin, T
    Altman, A
    Gordon, B
    Steinherz, L
    Weitman, S
    Steinherz, P
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1917 - 1923
12345